This is from the patent application involving the WT1 Vaccine, Galinpepimut-S (GPS) Notice it was originally used as a... “Vaccine for the prevention of breast cancer relapse” in 2014 by the Henry M. Jackson Foundation and in 2018 through Galena (The company that $SLS reverse-merged with in 2017) Is now a “Peptide vaccine therapy for treatment of FRα-expressing tumors” I can’t really break this down any further. This statement alone is proof that GPS is a cancer vaccine worth investing in. It wasn’t abandoned or even followed-through with in 2014 - instead it was promoted. And now we have it.
  • 15